Comparison of the efficacy and safety of Empagliflozin and Dapagliflozin in uncontrolled type 2 diabetic patients. (2025). Latakia University Journal -Medical Sciences Series, 46(5), 303-316. https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/18331